Vital Venture Capital
Venture capitalWashington · Series A–Growth · 5 people tracked
Investment thesis
Vital Venture Capital pursues a patient, value-oriented investment strategy, prioritizing companies led by founders who are honest, forthright, and operationally disciplined. The firm favors visionary leaders motivated by long-term exit value rather than high salaries, and it seeks to foster positive, innovative, and results-driven environments within its portfolio companies.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & public directoriesWhat they invest in
from 12 of 19 portfolio companiesBiotech ×6Healthtech ×6AI & Machine Learning ×5Deep Tech ×5Cybersecurity ×3AgTech ×2Hardware ×2Medical Devices ×2
HQs:United States×8
Investments · 19 tracked
founders shown can be your intro path
Ginkgo Bioworks builds autonomous labs and offers cell-programming and bioengineering services for the biopharma, agriculture, and industrial biotech markets.
AgTechAI & Machine LearningBiotechDeep TechHealthtechBoston, US
Jason Kelly(Founder)inAustin Che(Founder)inTom Knight(Founder)inBarry Canton(Founder)inReshma Shetty(Founder)in
BoardReshma Sohoni
Co-investors11.2 CapitalB3 HoldingCannage CapitalCool Climate CollectiveDCVC (Data Collective)Designer Fund+15 more
Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals.
BiotechDeep TechSemiconductorsSouth San Francisco, US
Emily Marine Leproust(Executive Officer, Director, Promoter)William Charles Banyai(Executive Officer, Director, Promoter)Bill James Peck(Executive Officer, Promoter)Emily Leproust(Founder)in
BoardKeith Crandell(Director)Paul Conley(Director)in
Co-investors+ND Capital3E Bioventures CapitalARCH Venture PartnersAsset Management CompanyBay City CapitalBlack Opal Ventures+7 more
10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers.
BiotechDeep TechHardwareHealthtechPleasanton, US
Serge Saxonov(Founder)inBen Hindson(Founder)in
Co-investorsOMX VenturesSoftBank Vision FundPaladin Capital Group
Co-investorsConnecticut Innovations
Bio-Rad develops instruments, reagents, quality control solutions, and data tools for life science research and clinical diagnostics.
BiotechHealthtechMedical Devices
Co-investorsID Ventures
Booker is an all-in-one management software platform for spas, salons, barbershops, and massage studios.
Co-investorsEscalate Capital PartnersRevolution
Circadence develops gamified, cloud-based cybersecurity training and awareness platforms for individuals, teams, and government agencies.
AI & Machine LearningCybersecurityDefense TechEdTech
Michael J. Moniz(Co-founder, President, and CEO)Christopher T. Blisard(Co-founder and Chief Operating Officer)
Co-investorsRunway Growth Capital
San Ramon, US
Samir Shah(Executive Officer, Director, Promoter)Nirav Shah(Executive Officer)
BoardAmit Sheth(Director)Anik Bose(Director)Paresh Zaveri(Director)Gregory J. Corona(Director)
Isolation Bio (Galt Inc.) develops the Prospector Discovery Platform, a high-throughput, automated microbial cultivation array technology that isolates, cultivates, and screens thousands of microbes in parallel.
AgTechBiotechDeep Tech
Co-investorsVertical Venture Partners
Co-investorsOsage Venture Partners
HealthtechChandler, US
David Smith(Executive Officer)Bill Colston(Executive Officer, Director)
BoardCraig Asher(Director)Caren Masen(Director)Carolyn Compton(Director)Paul Conley(Director)
Co-investorsThird Point Ventures
LookingGlass, now part of ZeroFox, provides attack surface monitoring enriched with threat intelligence to help organizations manage cyber risk and vulnerabilities.
AI & Machine LearningCybersecuritySaaS
Co-investorsAlsop Louie PartnersNeuberger Berman
Co-investorsPartners for GrowthPartners for Growth (PFG)
Rubryc discovers antibody-based medicines for obesity and cardiometabolic disease, using an AI-assisted platform to design antibodies for hard-to-drug targets.
AI & Machine LearningBiotechDeep TechSan Ramon, US
Paul Conley(Director)Bill Colston(Executive Officer, Director, Promoter)Jason Hong(Director)Isaac J. Bright(Executive Officer, Director)
Co-investorsThird Point VenturesPaladin Capital Group
Mclean, US
Christopher B. Key(Executive Officer, Director, Promoter)Christopher Key(Founder)inBenito A. Cianciaruso, Jr.(Executive Officer, Promoter)
BoardCharles Beeler(Director)Matt Bigge(Director)inJay Leek(Director)
Co-investorsBessemer Venture PartnersCisco InvestmentsClearSkyCrosslink CapitalSyn Ventures Seed Management LlcTen Eleven+3 more
Exits · 3
IPOs and acquisitions across the tracked portfolioGinkgo BioworksNYSE: DNATwist BioscienceNASDAQ: TWSTBioclinicaacq. by Clario
Portfolio news
latest coverage across their companies
Ginkgo Bioworks · kavout.com · Jun 21, 2026
Circadence · fintech.global · Mar 6, 2026
Bioclinica · appliedclinicaltrialsonline.com · Sep 16, 2025
Frequently asked questions
- How many investments has Vital Venture Capital made?
- Vital Venture Capital has 18 tracked investments, 3 of which have exited via acquisition or IPO.
- What stage does Vital Venture Capital invest at?
- Vital Venture Capital invests at the Series A, Series B, Series C, Growth stages.
- What is Vital Venture Capital's typical check size?
- Vital Venture Capital typically writes checks of $1M – $3M.
- What sectors does Vital Venture Capital focus on?
- Vital Venture Capital focuses on Digital Health, Enterprise Software, Healthtech, Medical Devices, SaaS.
- Where is Vital Venture Capital located?
- Vital Venture Capital is headquartered in Washington, US.
- Does Vital Venture Capital lead rounds?
- Yes, Vital Venture Capital leads investment rounds.
- Who does Vital Venture Capital co-invest with?
- Vital Venture Capital most often shares deals with iGlobe Partners, OMX Ventures, Bessemer Venture Partners, among 48 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
Atinum Investment Co., Ltd. is a Korean venture capital firm based in Seoul that invests across deep tech (AI, semiconductors, robotics, mobility), bio/healthcare, IT services/platforms, SaaS, consumer, and games/content.